Research Capabilities

Why choose MARC to deliver your research

With over three decades of specialist experience, dedicated facilities and a highly skilled multidisciplinary team, MARC provides a dependable, high-quality environment for dementia clinical research.

Dr. Jay Amin
Associate Professor in Psychiatry of Older Age and Honorary Consultant in Older People's Mental Health

“At MARC our internationally recognised studies range from landmark clinical trials in The Lancet, NEJM and Nature Medicine to pioneering research in neuroinflammation, stress, and innovative treatments. They are transforming how we understand, diagnose, and treat dementia. By combining scientific excellence with compassionate clinical care, we are driving real progress and bringing hope to people and families affected by dementia today and in the future”

Extensive Experience

Over 35 years of experience delivering dementia clinical trials
Expertise across preclinical, Phase 2 and Phase 3 CTIMPs
Highly experienced multidisciplinary team including psychiatrists, nurses, psychologists, raters and governance staff
Strong competency in a wide range of clinical scales, cognitive assessments and e-CRF systems
Large and diverse clinical population, with established referral pathways across Hampshire and the Isle of Wight

Specialist facilities and clinical infrastructure

Six fully equipped clinical rooms for physical examinations and memory assessments
Comfortable waiting areas with drinks, activities and access to a therapeutic garden
Access to local laboratories for biological sample analysis
Established links with neuroradiology partners offering MRI and PET imaging
On-site licensed pharmacist and secure pharmacy facilities for trial drug storage and dispensing
Dedicated, secure research laboratory for biological sample processing

Advanced biological sample handling

Fully trained staff for safe collection and processing of blood, CSF, and other biological samples
Temperature-controlled laboratory with certified equipment
24/7 alarmed –80°C and –20°C freezers for compliant long-term sample storage

Why Sponsors Choose MARC

Our experience, facilities and commitment to high-quality research enable us to deliver reliable outcomes, low screen-failure rates and smooth study set-up processes. As part of one of the UK’s largest community NHS Trusts, we offer strong clinical links, a large participant database, and the assurance that every study is delivered to rigorous professional standards.

What Sponsors Can Expect

Proven expertise: Over three decades of experience delivering Phase 2 and Phase 3 dementia trials.

High-quality data: Experienced raters, robust procedures and low screen-failure rates, even in preclinical studies.

Strong participant access: Large, research-ready database supported by referrals from across one of the UK’s largest community NHS Trusts.

Efficient set-up: Dedicated research governance team ensuring streamlined approvals and rapid study activation.

Specialist facilities: Six clinical rooms, on-site pharmacy, secure lab, MRI/PET partnerships, and –80°C/–20°C sample storage.

Advanced sample handling: Fully trained staff for blood and CSF collection, processing and storage using temperature-controlled systems.

GCSA-accredited site: Independently recognised for meeting high global standards for clinical trial delivery.

Experienced multidisciplinary team: Psychiatrists, psychologists, nurses and research professionals with extensive CTIMP experience.

A Trusted Partner in Dementia Research

Sponsors choose MARC for our proven ability to deliver complex dementia studies with precision, reliability and participant-centred care. Our infrastructure, expertise and reach across Hampshire and the Isle of Wight make us a leading site for commercial and academic partners in dementia research.

Get in Contact

Get in contact to discuss how we can support your research delivery.

Contact

Study Participant

I decided to participate in a dementia research study after being diagnosed with Alzheimer’s disease. The comprehensive assessments and screenings not only helped me to understand my condition better but also made me feel proactive in managing my health. The researchers at MARC were compassionate and knowledgeable. Being part of the research also gave me a sense of purpose, knowing that my involvement could contribute to finding better treatments and understanding for future generations”.